FindMyRecallSubscribe
Class I: serious health riskTerminated

Reumofan Plus Recall

Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and R…

Reumofan Plus USA · Springfield, PA

Risk level
Class I
Reported by FDA
Aug 14, 2013
Recall ID
D-837-2013
Check your lot numberHow we source this data

Summary

Reumofan Plus recalled Reumofan Plus starting Jan 4, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-837-2013 on Aug 14, 2013. Reason: Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol. Status: Terminated.

Why it was recalled

Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.

Product description

Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.

Lot numbers, UPCs & expiration codes

Lot #: 99515, Exp 09/2016

Where it was sold

Nationwide through internet sales.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-837-2013
Classification
Class I
Status
Terminated
Recall initiated
Jan 4, 2013
FDA report date
Aug 14, 2013
Quantity
586 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Reumofan Plus USA

Original FDA data

Every field from FDA enforcement report D-837-2013, exactly as published.

Show all FDA fields
City
Springfield
State
PA
Status
Terminated
Country
United States
Event ID
64182
Address
737 Buttonwood Dr.
Code information
Lot #: 99515, Exp 09/2016
Postal code
19064
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-837-2013
Classification
Class I
Recalling firm
Reumofan Plus USA
Product quantity
586 bottles
Termination date
Jan 29, 2015
Reason for recall
Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.
Distribution pattern
Nationwide through internet sales.
Recall initiation date
Jan 4, 2013
Initial firm notification
Letter
Center classification date
Aug 2, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-837-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls